This study examined the 24-hour hormone profiles of TSH, free T3, and free T4 in 20 hypothyroid patients, comparing those on combined T3/T4 therapy (n=10) with those on T4 monotherapy (n=10). Patients on combined therapy experienced a 42% increase in fT3 levels within 4 hours post-dose, while those on T4
